Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5339518 | 6331711 | I | 5339518-6 | 20060109 | 20060303 | 20070404 | PER | 2006022085 | PFIZER INC | 42 | YR | F | N | 150 | LBS | 20070328 | MD | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5339518 | 1008532885 | PS | GEODON | 1 | INTRAVENOUS | 20 MG (20 MG, 1 IN 1 D), INTRAVENOUS | Y | D | 20919 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5339518 | 1008532885 | CORONARY ARTERY DISEASE |
Outcome of event
Event ID | OUTC COD |
---|---|
5339518 | HO |
5339518 | OT |
Reactions reported
Event ID | PT |
---|---|
5339518 | NEUROLEPTIC MALIGNANT SYNDROME |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
5339518 | CR |
5339518 | HP |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5339518 | 1008532885 | 20060109 | 20060110 |